Post-ischemic azotemia as a partial 'brake', slowing progressive kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1455-1462

  Zager, Richard A ^a   Johnson, Ali C ^a   Becker, Kirsten ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

acute kidney injury; chronic kidney disease; KI 67; MCP 1; N acetyl glucosaminidase

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY MASS; KIDNEY SIZE; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; UREMIA;

ACUTE KIDNEY INJURY; CHRONIC KIDNEY DISEASE; KI-67; MCP-1; N-ACETYL GLUCOSAMINIDASE;

ACETYLGLUCOSAMINIDASE; ANIMALS; AZOTEMIA; IMMUNOENZYME TECHNIQUES; KIDNEY DISEASES; MALE; MICE; RENAL CIRCULATION; REPERFUSION INJURY; UREMIA;

EID: 84879875109     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft040     Document Type: Article

References (27)

1. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 2000; 109: 665-678
2. Dong Z, Saikumar P, Weinberg JM et al. Calcium in cell injury and death. Annu Rev Pathol 2006; 1: 405-434
3. Zager RA, Schimpf BA, Gmur DJ. Physiological pH. Effects on posthypoxic proximal tubular injury. Circ Res 1993; 72: 837-846
4. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. Am Soc Nephrol 2003; 14: 2199-2210
5. Devarajan PJ. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520
6. Zager RA, Johnson AC, Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and 'end-stage' kidney disease. Am J Physiol 2011; 301: F1334-F1345
7. Jo SK, Yun SY, Chang KH et al. Alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 2001; 16: 1583-1591
8. Jung M, Sola A, Hughes J et al. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney Int 2012; 81: 969-982
9. Cirillo O, Sautin YY, Kanellis J et al. Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant 2009; 24: 1384-1387
10. Snaedal S, Heimbürger O, Qureshi AR et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009; 53: 1024-1033
11. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNFalpha: central factors in the altered cytokine network of uremia- the good the bad and the ugly. Kidney Int 2005; 67: 1216-1233
12. Himmelfarb J, Stenvinkel P, Ikizler TA et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538
13. Zager RA. Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury. Am J Physiol 2009; 296: F362-F368
14. Zager RA, Johnson AC, Lund S. Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol 2009; 297: F961-F970
15. Bourbouze R, Baumann F-C, Bonvalet J-P et al. Distribution of N-acetyl-D-glucosaminidase isoenzymes along the rabbit nephron. Kidney Int 1984; 25: 636-642
16. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322
17. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395
18. Nakano K, Watney E, McDougall JK. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol 1998; 153: 857-864
19. Rowley SD, Bensinger WI, Gooley TA et al. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-2276
20. Basile DP, Friedrich JL, Spahic J et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol 2011; 300: F721-F733
21. Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol 2008; 295: F1648-F1657
22. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395
23. Krysko DV, Agostinis P, Krysko O et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32: 157-164
24. Zager RA, Timmerman TP, Merola AJ. Effects of immediate blood flow enhancement on the postischemic kidney: functional, morphologic, and biochemical assessments. J Lab Clin Med 1985; 106: 360-368
25. Zager RA. Alterations of intravascular volume: influence on renal susceptibility to ischemic injury. J Lab Clin Med 1986; 108: 60-69
26. Zager RA, Foerder C, Bredl C. The influence of mannitol on myoglobinuric acute renal failure: functional, biochemical, and morphological assessments. J Am Soc Nephrol. 1991; 4: 848-855
27. The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. New Engl J Med 2008; 359: 7-20